Both plasma and urine TGF-β1 levels are higher in patients with HCC than in those with cirrhosis, display comparable diagnostic ability as AFP to discriminate HCC from cirrhosis (Song et al. 2002; Tsai et al. 1997). The gene discussed is TGFB1; the disease is hepatocellular carcinoma.